AXGN
AxoGen, Inc. · Healthcare · Medical - Devices
Momentum-inputs (vergelijkbare managers):
breedte van houders -18.8% ·
aandelenstroom -3.2% ·
netto nieuwe posities -20.0%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 97 | +13 | 31.59M | $1.46B | +13 | −1 |
| Q1 2026 | 88 | +4 | 26.93M | $890.85M | +13 | −9 |
| Q4 2025 | 84 | +1 | 23.54M | $770.31M | +1 | — |
| Q3 2025 | 15 | 0 | 12.88M | $229.79M | +1 | −2 |
| Q2 2025 | 13 | -3 | 10.16M | $110.24M | — | −3 |
| Q1 2025 | 13 | +1 | 4.00M | $74.03M | +1 | — |
| Q4 2024 | 12 | +1 | 2.94M | $48.52M | +2 | −1 |
| Q3 2024 | 10 | +4 | 2.95M | $41.31M | +4 | — |
| Q2 2024 | 6 | — | 2.53M | $18.31M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 3.50M | — | $37.98M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 3.50M | — | $37.98M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 3.50M | — | $37.98M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 3.50M | — | $37.98M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 3.50M | — | $37.98M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 3.50M | — | $37.98M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 3.50M | — | $37.98M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 3.50M | — | $37.98M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 3.50M | — | $37.98M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 3.50M | — | $37.98M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 3.50M | — | $37.98M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passief) | 2.73M | — | $29.62M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passief) | 2.73M | — | $29.62M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passief) | 2.73M | — | $29.62M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passief) | 2.73M | — | $29.62M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passief) | 2.73M | — | $29.62M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (passief) | 1.12M | +10.7% | $12.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Geode Capital Management ✦ (passief) | 1.06M | +3.3% | $11.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | Geode Capital Management ✦ (passief) | 1.06M | +3.3% | $11.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Marshall Wace ✦ | 641.43K | -4.0% | $6.96M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | Marshall Wace ✦ | 641.43K | -4.0% | $6.96M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 448.43K | -20.3% | $4.87M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | Fidelity (FMR) ✦ | 268.87K | — | $2.92M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Fidelity (FMR) ✦ | 268.87K | — | $2.92M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Renaissance Technologies ✦ | 142.00K | +129.0% | $1.54M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 26 | Millennium Management ✦ | 104.39K | +805.4% | $1.13M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Norges Bank ✦ (passief) | 61.10K | -20.6% | $662,935 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | T. Rowe Price ✦ | 39.40K | +9.4% | $428,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Arrowstreet Capital ✦ | 29.12K | -70.1% | $315,974 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 30 | Two Sigma Investments ✦ | 10.96K | -93.3% | $118,916 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Citadel Advisors | $3.78M | was 0.0% |
| Point72 Asset Management | $982,350 | was 0.0% |
| AQR Capital Management | $442,465 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 219 houders, 49.68M aandelen, $1.61B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Director · 13.35K aand · $646,592
Officer · 67.50K aand · $3.20M
Director · 14.15K aand · $640,967
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie